These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18287023)

  • 1. A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.
    Cheng G; Montero A; Gastaminza P; Whitten-Bauer C; Wieland SF; Isogawa M; Fredericksen B; Selvarajah S; Gallay PA; Ghadiri MR; Chisari FV
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3088-93. PubMed ID: 18287023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of virocidal peptide derived from NS5A against two different HCV genotypes: an in vitro study.
    El-Shenawy R; Tabll A; Bader El Din NG; El Abd Y; Mashaly M; Abdel Malak CA; Dawood R; El-Awady M
    J Immunoassay Immunochem; 2015; 36(1):63-79. PubMed ID: 24606010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new natural α-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV.
    Yan R; Zhao Z; He Y; Wu L; Cai D; Hong W; Wu Y; Cao Z; Zheng C; Li W
    Peptides; 2011 Jan; 32(1):11-9. PubMed ID: 20950663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infection.
    Zhang J; Mulvenon A; Makarov E; Wagoner J; Knibbe J; Kim JO; Osna N; Bronich TK; Poluektova LY
    Biomaterials; 2013 May; 34(15):3846-57. PubMed ID: 23403120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.
    Liu X; Huang Y; Cheng M; Pan L; Si Y; Li G; Niu Y; Zhao L; Zhao J; Li X; Chen Y; Yang W
    J Virol; 2013 Feb; 87(3):1649-57. PubMed ID: 23175359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro.
    Hong W; Lang Y; Li T; Zeng Z; Song Y; Wu Y; Li W; Cao Z
    J Biol Chem; 2015 Sep; 290(38):23254-63. PubMed ID: 26251517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus.
    Bobardt MD; Cheng G; de Witte L; Selvarajah S; Chatterji U; Sanders-Beer BE; Geijtenbeek TB; Chisari FV; Gallay PA
    Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5525-30. PubMed ID: 18378908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of an amphipathic alpha-helical peptide's antiviral activity involves size-dependent virus particle lysis.
    Cho NJ; Dvory-Sobol H; Xiong A; Cho SJ; Frank CW; Glenn JS
    ACS Chem Biol; 2009 Dec; 4(12):1061-7. PubMed ID: 19928982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
    Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
    J Virol; 2019 May; 93(10):. PubMed ID: 30842319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin inhibitor tacrolimus does not interfere with the suppression of hepatitis C virus infection by interferon-alpha.
    Pan Q; Metselaar HJ; de Ruiter P; Kwekkeboom J; Tilanus HW; Janssen HL; van der Laan LJ
    Liver Transpl; 2010 Apr; 16(4):520-6. PubMed ID: 20373462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.
    Li GR; He LY; Liu XY; Liu AP; Huang YB; Qiu C; Zhang XY; Xu JQ; Yang W; Chen YX
    Chem Biol Drug Des; 2011 Nov; 78(5):835-43. PubMed ID: 21801309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV peptide (C5A), an amphipathic α-helical peptide of hepatitis virus C, is an activator of N-formyl peptide receptor in human phagocytes.
    Lin Q; Fang D; Hou X; Le Y; Fang J; Wen F; Gong W; Chen K; Wang JM; Su SB
    J Immunol; 2011 Feb; 186(4):2087-94. PubMed ID: 21228351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of peptides binding to HCV e2 and inhibiting viral infectivity.
    Hong HW; Lee SW; Myung H
    J Microbiol Biotechnol; 2010 Dec; 20(12):1769-71. PubMed ID: 21193836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoterminal amphipathic α-helix AH1 of hepatitis C virus nonstructural protein 4B possesses a dual role in RNA replication and virus production.
    Gouttenoire J; Montserret R; Paul D; Castillo R; Meister S; Bartenschlager R; Penin F; Moradpour D
    PLoS Pathog; 2014 Oct; 10(10):e1004501. PubMed ID: 25392992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.
    Tanabe Y; Sakamoto N; Enomoto N; Kurosaki M; Ueda E; Maekawa S; Yamashiro T; Nakagawa M; Chen CH; Kanazawa N; Kakinuma S; Watanabe M
    J Infect Dis; 2004 Apr; 189(7):1129-39. PubMed ID: 15031779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SELECTIVE INHIBITION OF HEPATITIS C VIRUS REPLICATION BY ALPHA-ZAM, A
    Oyero OG; Toyama M; Mitsuhiro N; Onifade AA; Hidaka A; Okamoto M; Baba M
    Afr J Tradit Complement Altern Med; 2016; 13(6):144-148. PubMed ID: 28480371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A screen for genetic suppressor elements of hepatitis C virus identifies a supercharged protein inhibitor of viral replication.
    Simeon RL; Chen Z
    PLoS One; 2013; 8(12):e84022. PubMed ID: 24391867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
    Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
    World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.
    Liu R; Tewari M; Kong R; Zhang R; Ingravallo P; Ralston R
    Antiviral Res; 2010 May; 86(2):172-9. PubMed ID: 20156485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.